Multiple Endocrinology Immune-Related Adverse Events (irAEs) Related to Pembrolizumab as Neoadjuvant Treatment in Two Cases of TNBC Patients: Case Reports and Literature Review.
Simple Summary: irAEs can happen in any patient receiving ICIs, either in a metastatic or non-metastatic setting. Given their increasing application in clinical practice, understanding the underlying causes and manifestations, as well as diagnosis and management, is of great importance, making it on...
| Publicado en: | Current Oncology Vol. 31; no. 1; pp. 28 - 44 |
|---|---|
| Autores principales: | , , , , , , , |
| Formato: | Journal Article |
| Publicado: |
MDPI
Jan2026
|
| Acceso en línea: | Ver este registro en EBSCOhost |